{
    "@graph": [
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A614476550",
            "@type": "bibo:Thesis",
            "P1053": "Online-Ressource (PDF-Datei: ca. 80 S., 2,4 MB)",
            "creator": "Fehr, Andr\u00e9",
            "identifier": [
                "(firstid)GBV:614476550",
                "(ppn)614476550"
            ],
            "publisher": "Staats- und Universit\u00e4tsbibliothek [Host]",
            "subject": [
                "(classificationName=ddc-dbn)570",
                "(classificationName=linseach:mapping)bio"
            ],
            "title": "Untersuchungen zur Genetik von Speicheldr\u00fcsentumoren",
            "abstract": "Mucoepidermoid carcinoma, Warthin's tumor, CRTC1-MAML2, HMGA2, molecular biomarker, prognostic significance. - We have analyze the recently for mucoepidermoid carcinoma (MEC) and Warthin's tumor (WAT) described gene fusion CRTC1-MAML2 for its diagnostic potential as biomarker and to find out if an aberrant HMGA2 expression level influence tumorgenesis of MECs. Our studies have shown that a CRTC1-MAML2 test is a powerful tool for diagnosis and prognosis of MECs. The fusion correlates with a low- or intermediate-grade of the tumor and is associated with a favorable prognosis. CRTC1-MAML2 negative tumors were mainly found in high-grade tumors and show a significant increased HMGA2 level. These data raise doubts about the correct classification of MECs into low-, intermediate- and high-grade tumors. In our opinion the present classification of MECs includes two subgroups: A huge group of \"true-MECs\" with the CRTC1-MAML2 fusion, with a moderate aggressiveness and furthermore a group of morphological heterogeneous tumors lacking this fusion and with an aberrantly high HMGA2 expression level.",
            "alternative": "Genetic Analyses of Salivary Gland Tumors",
            "contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)GBV-ODiss",
            "issued": "2009",
            "language": "http://id.loc.gov/vocabulary/iso639-1/de",
            "license": "commercial licence",
            "medium": "rda:termList/RDACarrierType/1018"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "license": "http://purl.org/dc/terms/license",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "creator": "http://purl.org/dc/elements/1.1/creator",
        "issued": "http://purl.org/dc/terms/issued",
        "alternative": "http://purl.org/dc/terms/alternative",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "title": "http://purl.org/dc/elements/1.1/title",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "contributor": "http://purl.org/dc/terms/contributor",
        "abstract": "http://purl.org/dc/terms/abstract",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}